These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10819711)

  • 1. Chronic infection and coronary risk.
    Mogadam M
    Ann Intern Med; 2000 May; 132(10):842. PubMed ID: 10819711
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of Chlamydia pneumoniae in the normal population.
    Stolk-Engelaar MV; Peeters MF
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):478. PubMed ID: 1425723
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae infection in the course of chronic asthma in children].
    El Hayek J; Hoeusler V; Castelain MC; Huvenne H; Moukagni M; Raymond J; Kalach N
    Arch Pediatr; 2009 Aug; 16(8):1189-90. PubMed ID: 19570661
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of Chlamydia pneumoniae IgG antibodies in patients with coronary artery disease: a report from an Indian population.
    Perumal V; Mathai E; Jose J; Gupta S
    Indian Heart J; 2003; 55(6):667. PubMed ID: 14989526
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies against Chlamydia pneumoniae and their relation to lymphocyte population levels.
    González-Castañeda C; Pérez-Castrillón JL; Romero-Gómez M; Herreros-Fernández V
    Int J Cardiol; 2002 Mar; 82(3):293-5. PubMed ID: 11911918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods.
    Paldanius M; Leinonen M; Virkkunen H; Tenkanen L; Sävykoski T; Mänttäri M; Saikku P
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):233-9. PubMed ID: 16757141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there something more behind atherosclerotic plaque inflammation?
    Gurfinkel E
    Eur Heart J; 1998 May; 19(5):677-8. PubMed ID: 9716993
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlamydia pneumoniae and lipoprotein(a): the right combination for atherosclerosis?
    Cassone A
    Eur Heart J; 2000 Apr; 21(8):599-600. PubMed ID: 10731393
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlamydia pneumoniae--seroprevalance among adults presenting with acute community-acquired pneumonia (CAP).
    Warrier R; Brahmadattan KN; Muthiah AS; Cherian AO; Mathai D
    J Assoc Physicians India; 2006 Jan; 54():77-8. PubMed ID: 16649745
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.
    Saikku P; Leinonen M; Tenkanen L; Linnanmäki E; Ekman MR; Manninen V; Mänttäri M; Frick MH; Huttunen JK
    Ann Intern Med; 1992 Feb; 116(4):273-8. PubMed ID: 1733381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae and acute coronary syndrome.
    Wong BY; Gnarpe J
    N Engl J Med; 2005 Aug; 353(5):525-8; author reply 525-8. PubMed ID: 16079381
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlamydia pneumoniae as risk factor of cardiovascular disease in dialysis patients.
    Sessa R; Di Pietro M; Ratanarat R; Rassu M; Ronco C
    Int J Artif Organs; 2005 Jan; 28(1):3-7. PubMed ID: 15742303
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlamydia pneumoniae IgG seropositivity and clinical history of ischemic heart disease in Singapore.
    Koh WP; Taylor MB; Chew SK; Phoon MC; Kang KL; Chow VT
    J Microbiol Immunol Infect; 2003 Sep; 36(3):169-74. PubMed ID: 14582560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae seropositivity and risk of developing coronary heart disease in Western Saudi Arabia.
    Momenah AM; Tayeb MT
    Saudi Med J; 2005 Dec; 26(12):1926-9. PubMed ID: 16380774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for coronary heart disease and persistent infection with Chlamydia pneumoniae or cytomegalovirus: a population-based study.
    Danesh J; Wong Y; Ward M; Muir J
    J Cardiovasc Risk; 1999 Dec; 6(6):387-90. PubMed ID: 10817084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Chlamydophila pneumoniae in ischaemic heart disease.
    Monno R; Fumarola L; Trerotoli P; Giannelli G; Correale M; Brunetti D; Di Biase M
    New Microbiol; 2010 Oct; 33(4):381-5. PubMed ID: 21213597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prevalence of anti-Chlamydia trachomatis and anti-Chlamydia pneumoniae antibodies in Brazzaville].
    Biendo M; Lefebvre JF; Fuentes V; Orfila J
    Bull Soc Pathol Exot; 1994; 87(2):85-8. PubMed ID: 8061533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chlamydia pneumoniae in patients with atherosclerotic ischemia of the lower limbs].
    Drozdz W; Zawilińska B; Wysocki A; Kleszcz E; Wilczek M
    Przegl Lek; 2003; 60 Suppl 7():53-5. PubMed ID: 14679694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association of chronic Chlamydia pneumoniae infection with chronic fatigue syndrome.
    Komaroff AL; Wang SP; Lee J; Grayston JT
    J Infect Dis; 1992 Jan; 165(1):184. PubMed ID: 1727893
    [No Abstract]   [Full Text] [Related]  

  • 20. An association of an antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan.
    Miyashita N; Toyota E; Sawayama T; Matsushima T
    Eur Heart J; 1998 Jun; 19(6):971. PubMed ID: 9651727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.